Vaccine refusal lower in minorities in new study

(Press-News.org) BOSTON (Oct. 24, 2024) – Throughout the Covid pandemic, media widely reported that Black patients were more likely than White patients to refuse vaccines, including the influenza and Covid vaccines. A new study being presented at this year’s American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting in Boston showed that self-identified non-White patients were less likely to demonstrate vaccine-hesitancy than the self-identified White patient group.

“We found some surprising results from our study, including that minority patients were less likely to demonstrate vaccine hesitancy,” says Albert Wu, MD, lead author of the study. “Allergy and immunology patients may be immunocompromised and at higher risk for infections, so identifying vaccine-hesitant groups is essential to protecting these individuals and those at risk in the community. Our goal was to analyze patient characteristics and factors associated with influenza and COVID vaccine hesitancy in a clinic in a diverse community.”

The site of the study was an allergy clinic primarily serving the Brooklyn area of New York City. The clinic serves several zip codes predominantly below the median household income in the city as well as the least vaccinated zip codes in the city. It also serves communities of patients who are primarily immigrants.

Ethnicities included in the study included: White (37.2%), Hispanic (31.6%), Asian (18.9%), and Black (12.1%). 80% of the patient group spoke English as their primary language. In this study, 39 people (11.54%) refused both the influenza and COVID vaccine. Of the 39, distribution in each category was: White, 17.5%, Hispanic, 11.4%, Asian, 4.76%, and Black 4.9%. Gender, age, and language were not significantly associated with vaccine refusal rate.

“We felt a significant portion of vaccine hesitant patients were influenced by a feeling of mistrust of authority,” says allergist Mary Lee-Wong, MD, senior author on the study and ACAAI member. “While public health campaigns with generalized messages are effective, building a relationship of trust and partnership with patients can be extremely impactful and a key way that allergists can help address vaccine hesitancy.”

Abstract Title: VACCINE HESITANCY IN AN ALLERGY AND IMMUNOLOGY CLINIC IN AN UNDERSERVED COMMUNITY (Abstract below, table available in online abstract)

Presenter: Albert Wu, MD

For more information about food allergies, or to find an allergist in your area, visit AllergyandAsthmaRelief.org. The ACAAI Annual Scientific Meeting is Nov. 9-13. For more news and research from the ACAAI Scientific Meeting, go to our newsroom and follow the conversation on X/Twitter #ACAAI24.

About ACAAI

The American College of Allergy, Asthma & Immunology (ACAAI) is a professional medical organization of more than 6,000 allergists-immunologists and allied health professionals, headquartered in Arlington Heights, Ill. Founded in 1942, the College fosters a culture of collaboration and congeniality in which its members work together and with others toward the common goals of patient care, education, advocacy, and research. ACAAI allergists are board-certified physicians trained to diagnose allergies and asthma, administer immunotherapy, and provide patients with the best treatment outcomes. For more information and to find relief, visit AllergyandAsthmaRelief.org. Join us on Facebook, Pinterest, Instagram and X/Twitter.

R309
VACCINE HESITANCY IN AN ALLERGY AND IMMUNOLOGY CLINIC IN AN UNDERSERVED COMMUNITY
A. Wu*1, W. Drum2, H. Bao3, G. Lam4, K. Wathan5, D. Chan1, N. Silverberg6, (NM) M. Lee-Wong1, (Fellow) 1. New York, NY; 2. Goleta, CA; 3. Bronx, NY; 4. Suwanee, GA; 5. Reno, NV; 6. Brooklyn, NY.

Introduction: Allergy and immunology patients may be immunocompromised and at higher risk for infections. Identifying vaccine-hesitant groups is essential to protecting these individuals and those at risk in the community. Objective: To analyze patient characteristics and factors associated with influenza and COVID vaccine hesitancy in a clinic in a diverse community.

Methods: Vaccination history and demographic information were collected as part of intake questionnaires from 338 new patients presenting to an outpatient allergy/immunology clinic from March 2023 to February 2024. Data were analyzed using Microsoft Excel and R Studio.

Results: There were 94 men and 244 women (median age: 41; range 18-93). Ethnicities included: White 126 (37.2%), Hispanic 107 (31.6%), Asian 64 (18.9%), and Black 41 (12.1%). English primary language speakers encompassed 80% of the patient group. In this study, 39 (11.54%) refused both the influenza and COVID vaccine; Of the 39, distribution in each category was: White 22 (17.5%), Hispanic 12 (11.4%), Asian 3 (4.76%), Black 2 (4.9%). Gender, age, and language were not significantly associated with vaccine refusal rate. Ethnicity was found to be significant. In our study, self-identified non-White patients were less likely to demonstrate vaccine-hesitancy than the self-identified White patient group (OR 0.41, 95% CI 0.21-0.81). Conclusion: Many publications report minorities are more prone to vaccine-hesitancy, hindering herd immunity. Odds ratios for refusal of both vaccines were lower for minorities in this studied population. Focusing efforts on all patients may enhance vaccination initiatives.

 

END